Health Sciences

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

The Latest

UC San Diego is World’s 7th Best Public University, According to Times Higher Education

The University of California San Diego has been ranked the seventh best public university across the globe by Times Higher Education World University Rankings. In its 2016–17 report, the London-based publication ranked UC San Diego 22nd in the United States and 41st internationally.

UC San Diego a Prominent Presence at Startups Demo Day in D. C.

One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.

‘Inside Innovation’ Series at UC San Diego Kicks Off with Todd Coleman

“Inside Innovation,” a new series of free, public presentations, will feature the latest innovation technologies by UC San Diego, with opportunities for participants to get an inside look at what’s happening in our labs, explore commercialization opportunities, and inquire about licensing.

UC San Diego Professor Wins Top Academic Prize in Theoretical Chemistry

J. Andrew McCammon, a distinguished professor of chemistry, biochemistry and pharmacology at the University of California San Diego, has won this year’s most prestigious university-based prize in theoretical chemistry.

Nobel Laureate Roger Tsien Dies, Age 64

Roger Tsien, PhD, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died August 24 in Eugene, Ore. He was 64.

Flesh-Eating Infections in Rheumatoid Arthritis Patients Spur New Discovery

Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Streptococcal infections than patients not on the drug, according to University of California San Diego School of Medicine researchers. Their study, published August 19 in Science Immunology, also uncovers a critical new role for IL-1beta as the body’s independent early warning system for bacterial infections.